Literature DB >> 24084410

Invasion patterns in brain metastases of solid cancers.

Anna S Berghoff1, Orsolya Rajky, Frank Winkler, Rupert Bartsch, Julia Furtner, Johannes A Hainfellner, Simon L Goodman, Michael Weller, Jens Schittenhelm, Matthias Preusser.   

Abstract

BACKGROUND: Brain metastases are generally considered to be well demarcated from the surrounding brain parenchyma, although infiltrative growth patterns have been observed. We systemically investigated infiltration patterns and expression of adhesion molecules in a large and well-defined series of autopsy cases of brain metastases.
METHODS: Ninety-seven autopsy specimens from 57 brain metastasis patients (primary tumor: 27 lung cancer, 6 breast cancer, 8 melanoma, 2 colorectal cancer, 1 kidney cancer, and 13 other) were evaluated for patterns of invasion into surrounding brain parenchyma. Expression of integrins αv; cytoplasmic β3, αvβ3, αvβ5, αvβ6, and αvβ8; and of E and N cadherin were evaluated using immunohistochemistry.
RESULTS: Three main invasion patterns were seen: well-demarcated growth (29/57, 51%), vascular co-option (10/57, 18%), and diffuse infiltration (18/57, 32%). There was no statistically significant association of invasion pattern with primary tumor type, although vascular co-option was most common in melanoma brain metastases (4/10). Invasion patterns of different brain metastases of the same patient were highly concordant (P < .001, chi-square test). Distance of infiltration from the main tumor mass ranged from 12.5 µm to 450 µm (median 56.2 µm) and was not significantly different between the vascular co-option and the diffuse infiltration groups. Levels of αvβ6 were significantly higher in the well-demarcated group than in the vascular co-option and the diffuse infiltration groups (P = .033, Kruskal-Wallis test). Expression of αvβ5 in tumor cells was higher in brain metastasis lesions previously treated with stereotactic radiosurgery (P = .034, chi-square test).
CONCLUSIONS: Distinct invasion patterns of brain metastases into the brain parenchyma are not specific for primary tumor types, seem to be influenced by expression of αv integrin complexes, and may help to guide clinical decision-making.

Entities:  

Keywords:  adhesion molecules; brain metastases; cadherin; integrin; invasion

Mesh:

Substances:

Year:  2013        PMID: 24084410      PMCID: PMC3829586          DOI: 10.1093/neuonc/not112

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  31 in total

Review 1.  Role of integrins in cell invasion and migration.

Authors:  John D Hood; David A Cheresh
Journal:  Nat Rev Cancer       Date:  2002-02       Impact factor: 60.716

2.  A pathology-based substrate for target definition in radiosurgery of brain metastases.

Authors:  Brigitta G Baumert; Isabelle Rutten; Cary Dehing-Oberije; Albert Twijnstra; Miranda J M Dirx; Ria M T L Debougnoux-Huppertz; Philippe Lambin; Bela Kubat
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-07-11       Impact factor: 7.038

Review 3.  Brain metastases: epidemiology and pathophysiology.

Authors:  Igor T Gavrilovic; Jerome B Posner
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

4.  Prognostic relevance of intracytoplasmic cytokeratin pattern, hormone expression profile, and cell proliferation in pituitary adenomas of akromegalic patients.

Authors:  P R Mazal; T Czech; R Sedivy; M Aichholzer; J Wanschitz; N Klupp; H Budka
Journal:  Clin Neuropathol       Date:  2001 Jul-Aug       Impact factor: 1.368

5.  Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer.

Authors:  Federico Cappuzzo; Fred R Hirsch; Elisa Rossi; Stefania Bartolini; Giovanni L Ceresoli; Lynne Bemis; Jerry Haney; Samir Witta; Kathleen Danenberg; Irene Domenichini; Vienna Ludovini; Elisabetta Magrini; Vanesa Gregorc; Claudio Doglioni; Angelo Sidoni; Maurizio Tonato; Wilbur A Franklin; Lucio Crino; Paul A Bunn; Marileila Varella-Garcia
Journal:  J Natl Cancer Inst       Date:  2005-05-04       Impact factor: 13.506

6.  Longitudinal expression analysis of αv integrins in human gliomas reveals upregulation of integrin αvβ3 as a negative prognostic factor.

Authors:  Jens Schittenhelm; Esther I Schwab; Jan Sperveslage; Marcos Tatagiba; Richard Meyermann; Falko Fend; Simon L Goodman; Bence Sipos
Journal:  J Neuropathol Exp Neurol       Date:  2013-03       Impact factor: 3.685

7.  Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis.

Authors:  Fred R Hirsch; Marileila Varella-Garcia; Paul A Bunn; Michael V Di Maria; Robert Veve; Roy M Bremmes; Anna E Barón; Chan Zeng; Wilbur A Franklin
Journal:  J Clin Oncol       Date:  2003-09-02       Impact factor: 44.544

Review 8.  The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Mark E Linskey; David W Andrews; Anthony L Asher; Stuart H Burri; Douglas Kondziolka; Paula D Robinson; Mario Ammirati; Charles S Cobbs; Laurie E Gaspar; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

Review 9.  The role of surgical resection in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline.

Authors:  Steven N Kalkanis; Douglas Kondziolka; Laurie E Gaspar; Stuart H Burri; Anthony L Asher; Charles S Cobbs; Mario Ammirati; Paula D Robinson; David W Andrews; Jay S Loeffler; Michael McDermott; Minesh P Mehta; Tom Mikkelsen; Jeffrey J Olson; Nina A Paleologos; Roy A Patchell; Timothy C Ryken; Mark E Linskey
Journal:  J Neurooncol       Date:  2009-12-04       Impact factor: 4.130

10.  Antiangiogenic therapy of cerebral melanoma metastases results in sustained tumor progression via vessel co-option.

Authors:  William P J Leenders; Benno Küsters; Kiek Verrijp; Cathy Maass; Pieter Wesseling; Arend Heerschap; Dirk Ruiter; Andy Ryan; Robert de Waal
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

View more
  72 in total

Review 1.  The impact of cerebral metastases growth pattern on neurosurgical treatment.

Authors:  Marcel A Kamp; Philipp J Slotty; Jan F Cornelius; Hans-Jakob Steiger; Marion Rapp; Michael Sabel
Journal:  Neurosurg Rev       Date:  2016-07-09       Impact factor: 3.042

2.  Expression profiling of angiogenesis-related genes in brain metastases of lung cancer and melanoma.

Authors:  Aysegül Ilhan-Mutlu; Christian Siehs; Anna Sophie Berghoff; Gerda Ricken; Georg Widhalm; Ludwig Wagner; Matthias Preusser
Journal:  Tumour Biol       Date:  2015-08-16

3.  Genetic variants associated with colorectal brain metastases susceptibility and survival.

Authors:  S Stremitzer; A S Berghoff; N B Volz; W Zhang; D Yang; S Stintzing; Y Ning; Y Sunakawa; S Yamauchi; A Sebio; S Matsusaka; S Okazaki; D Hanna; A Parekh; A Mendez; M D Berger; R El-Khoueiry; P Birner; M Preusser; H-J Lenz
Journal:  Pharmacogenomics J       Date:  2015-12-22       Impact factor: 3.550

4.  αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer.

Authors:  Anna Sophie Berghoff; Astrid Kerstin Kovanda; Thomas Melchardt; Rupert Bartsch; Johannes A Hainfellner; Bence Sipos; Jens Schittenhelm; Christoph C Zielinski; Georg Widhalm; Karin Dieckmann; Michael Weller; Simon L Goodman; Peter Birner; Matthias Preusser
Journal:  Clin Exp Metastasis       Date:  2014-08-24       Impact factor: 5.150

5.  Postoperative local fractionated radiotherapy for resected single brain metastases.

Authors:  Ahmad Walid Ayas; Stefan Grau; Karolina Jablonska; Daniel Ruess; Maximilian Ruge; Simone Marnitz; Roland Goldbrunner; Martin Kocher
Journal:  Strahlenther Onkol       Date:  2018-09-14       Impact factor: 3.621

6.  Pre- and early postoperative GFAP serum levels in glioma and brain metastases.

Authors:  Peter Baumgarten; Johanna Quick-Weller; Florian Gessler; Marlies Wagner; Julia Tichy; Marie-Therese Forster; Christian Foerch; Volker Seifert; Michel Mittelbronn; Christian Senft
Journal:  J Neurooncol       Date:  2018-05-24       Impact factor: 4.130

Review 7.  Brain metastases: neuroimaging.

Authors:  Whitney B Pope
Journal:  Handb Clin Neurol       Date:  2018

Review 8.  Unsanctifying the sanctuary: challenges and opportunities with brain metastases.

Authors:  Shannon Puhalla; William Elmquist; David Freyer; Lawrence Kleinberg; Chris Adkins; Paul Lockman; John McGregor; Leslie Muldoon; Gary Nesbit; David Peereboom; Quentin Smith; Sara Walker; Edward Neuwelt
Journal:  Neuro Oncol       Date:  2015-05       Impact factor: 12.300

Review 9.  Tumor bed radiosurgery: an emerging treatment for brain metastases.

Authors:  Mark J Amsbaugh; Warren Boling; Shiao Woo
Journal:  J Neurooncol       Date:  2015-04-25       Impact factor: 4.130

10.  Quantification of PpIX-fluorescence of cerebral metastases: a pilot study.

Authors:  Johannes Knipps; Igor Fischer; Lisa M Neumann; Marion Rapp; Maxine Dibué-Adjei; Christiane Freiin von Saß; Jan-Malte Placke; Hendrik-Jan Mijderwijk; Hans-Jakob Steiger; Michael Sabel; Jan-Frederick Cornelius; Marcel A Kamp
Journal:  Clin Exp Metastasis       Date:  2019-08-02       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.